Efficacy Of Sahacharadi Taila Uttar Basti In The Management Of Chronic Lower UTI In Females .

Efficacy Of Sahacharadi Taila Uttar Basti In The Management Of Mutrakrichhram (Chronic Lower Urinary Tract Infections ) In Females An Open Labelled Randomized Standard Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084558

Enrollment

Registered

2025-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The only female patients of age 18 to 60 years. 2. The patients having either dysuria or any other signs and symptoms of Mutrakrichhram (Chronic lower urinary tract infections) 3. Patients with positive findings for urine R/M examination. 4. Recurrent / chronic UTI patients ( defined as occurrence of 2 or more UTIs within months or 3 within a year )

Exclusion criteria

Exclusion criteria: 1. Patients of age below 18 years and above 60 years. 2. Patients of acute UTI , acute cystitis, malignancy, congenital deformities of urogenital tract or any abdominal-pelvic pathology. 3. Systemic diseases like chronic renal failure (CRF), Uncontrolled Hypertension (BP greater than 150/90 mmHg), diabetes mellitus (RBS greater than 140 mg/dl), 4. Patient of k/c/o Tuberculosis, Paralysis, and Parkinsonism will be excluded. 5. Known case of cardiac diseases (H/O- MI, IHD). 6. Patient having HIV, HBsAg, HCV, VDRL positive 7. Renal failure 8. Pyelonephritis 9. Urinary calculi anywhere in the urinary tract 10. Pregnancy and lactating women and women with sweta pradara .

Design outcomes

Primary

Measure	Time frame
Relief in the features of Mutrakrichhram (chronic lower urinary tract infections) as mentioned in diagnostic criteria.Timepoint: 1 DAY, 8 DAYS	—

Secondary

Measure	Time frame
Absence of recurrence in follow up periodTimepoint: 15 day , 22 day	—

Countries

India

Contacts

Public ContactDr P B Joshi

Institute of Teaching and Research in Ayurveda Jamnagar

pbj@itra.edu.in9427226504

Outcome results